XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 257,996 $ 319,589
Investment securities, available-for-sale 589,023 436,404
Accounts receivable, net 115,850 98,739
Interest and other receivables 23,588 5,956
Inventory 29,097 21,949
Prepaid expenses 60,868 55,681
Total current assets 1,076,422 938,318
Property and equipment, net 3,708 4,215
Operating lease right-of-use assets 49,673 46,571
Intangible assets, net 111,615 119,782
Restricted cash 9,471 8,770
Long-term inventory 76,888 69,741
Other assets 2,994 359
Total assets 1,330,771 1,187,756
Liabilities and stockholders’ equity    
Accounts payable 21,747 16,192
Accrued liabilities 334,837 378,678
Total current liabilities 356,584 394,870
Operating lease liabilities 43,026 42,037
Other long-term liabilities 13,889 18,056
Total liabilities 413,499 454,963
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at September 30, 2025 and December 31, 2024; 169,146,043 shares and 166,708,856 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 16 16
Additional paid-in capital 3,003,221 2,936,871
Accumulated deficit (2,086,954) (2,204,386)
Accumulated other comprehensive income 989 292
Total stockholders’ equity 917,272 732,793
Total liabilities and stockholders’ equity $ 1,330,771 $ 1,187,756